Related references
Note: Only part of the references are listed.DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration
Giles Vermeire et al.
CANCER GENE THERAPY (2021)
Cell death due to electroporation - A review
Tina Batista Napotnik et al.
BIOELECTROCHEMISTRY (2021)
A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
Cheolmin Kim et al.
NATURE COMMUNICATIONS (2021)
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Emanuele Andreano et al.
CELL (2021)
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler et al.
CELL (2021)
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors
Michael Mor et al.
PLOS PATHOGENS (2021)
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum et al.
CELL (2021)
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies
Renhong Yan et al.
CELL RESEARCH (2021)
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients
Brian J. Boyarsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins
Ha V. Dang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2021)
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
Tal Noy-Porat et al.
ISCIENCE (2021)
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series
Caoilfhionn M. Connolly et al.
ANNALS OF INTERNAL MEDICINE (2021)
Neutralizing antibodies for the prevention and treatment of COVID-19
Lanying Du et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Adeno-Associated Virus Vector-Mediated Expression of Antirespiratory Syncytial Virus Antibody Prevents Infection in Mouse Airways
Josh Tycko et al.
HUMAN GENE THERAPY (2021)
Improved Potency and Safety of DNA-Encoded Antibody Therapeutics Through Plasmid Backbone and Expression Cassette Engineering
Giles Vermeire et al.
HUMAN GENE THERAPY (2021)
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
Laura A. VanBlargan et al.
IMMUNITY (2021)
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients
Andrew M. Hallett et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2021)
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Sokratis A. Apostolidis et al.
NATURE MEDICINE (2021)
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
Hyeseon Cho et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein
Michael P. Doyle et al.
CELL REPORTS (2021)
Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
Gihoon You et al.
VACCINES (2021)
The landscape of bispecific T cell engager in cancer treatment
Shujie Zhou et al.
BIOMARKER RESEARCH (2021)
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
Seth J. Zost et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
Ada Maria Barcelos Alves et al.
FRONTIERS IN MEDICAL TECHNOLOGY (2021)
In vivo delivery of synthetic DNA encoded antibodies induces broad HIV-1-neutralizing activity
Megan C. Wise et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge
Hyeree Choi et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies
Philipp A. Ilinykh et al.
CELL HOST & MICROBE (2020)
Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody
Urvi S. Zankharia et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Long-Term Delivery of an Anti-SIV Monoclonal Antibody With AAV
Jose M. Martinez-Navio et al.
FRONTIERS IN IMMUNOLOGY (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
DNA vaccines: prime time is now
Ebony N. Gary et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Jakob Kreye et al.
CELL (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
Seth J. Zost et al.
NATURE MEDICINE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer et al.
SCIENCE (2020)
Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity
Katherine Schultheis et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes
Tal Noy-Porat et al.
NATURE COMMUNICATIONS (2020)
The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies
Anna Vaisman-Mentesh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection
Wei Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys
Shuang Wang et al.
NATURE COMMUNICATIONS (2020)
Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases
Ziyang Xu et al.
FRONTIERS IN MEDICAL TECHNOLOGY (2020)
A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
Xiaoniu Miao et al.
MABS (2020)
Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation
Nina N. Schommer et al.
HUMAN GENE THERAPY (2019)
Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression
Jose M. Martinez-Navio et al.
IMMUNITY (2019)
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial
Frances H. Priddy et al.
LANCET HIV (2019)
In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus
Rianne N. Esquivel et al.
MOLECULAR THERAPY (2019)
A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection
Nurgun Kose et al.
SCIENCE IMMUNOLOGY (2019)
Bridging the Clinical Gap for DNA-Based Antibody Therapy Through Translational Studies in Sheep
Kevin Hollevoet et al.
HUMAN GENE THERAPY (2019)
Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
Jennifer M. Brannan et al.
NATURE COMMUNICATIONS (2019)
A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions
Leslie Goo et al.
NATURE MICROBIOLOGY (2019)
DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity
Alfredo Perales-Puchalt et al.
JCI INSIGHT (2019)
Gene Transfer of ZMapp Antibodies Mediated by Recombinant Adeno-Associated Virus Protects Against Ebola Infections
Marc-Andre Robert et al.
HUMAN GENE THERAPY (2018)
Monoclonal Antibody Cocktail Protects Hamsters From Lethal Marburg Virus Infection
Andrea Marzi et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Prolonged in vivo expression and anti-tumor response of DNA-based anti-HER2 antibodies
Kevin Hollevoet et al.
Oncotarget (2018)
Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine
Wen-Yang Tsai et al.
JOURNAL OF VIROLOGY (2018)
In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse Model
Ami Patel et al.
CELL REPORTS (2018)
Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge
Hugh C. Welles et al.
PLOS PATHOGENS (2018)
Bispecific antibodies for viral immunotherapy
Elisabeth K. Nyakatura et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys
Diogo M. Magnani et al.
MOLECULAR THERAPY (2017)
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
Norbert Pardi et al.
NATURE COMMUNICATIONS (2017)
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections
Chasity D. Andrews et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections
Sarah T. C. Elliott et al.
NPJ VACCINES (2017)
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
Moritz Thran et al.
EMBO MOLECULAR MEDICINE (2017)
Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus
Karuppiah Muthumani et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
Karuppiah Muthumani et al.
NPJ VACCINES (2016)
Recognition determinants of broadly neutralizing human antibodies against dengue viruses
Alexander Rouvinski et al.
NATURE (2015)
Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy
Seleeke Flingai et al.
SCIENTIFIC REPORTS (2015)
Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail
Jeffrey R. Kugelman et al.
CELL REPORTS (2015)
Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes
Rui Kong et al.
JOURNAL OF VIROLOGY (2015)
Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model
Justin G. Julander et al.
ANTIVIRAL RESEARCH (2014)
Adeno-Associated Virus 9-Mediated Airway Expression of Antibody Protects Old and Immunodeficient Mice against Influenza Virus
Virginie S. Adam et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
Alejandro B. Balazs et al.
NATURE MEDICINE (2014)
Broad protection against influenza infection by vectored immunoprophylaxis in mice
Alejandro B. Balazs et al.
NATURE BIOTECHNOLOGY (2013)
A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model
Brett A. Thibodeaux et al.
ANTIVIRAL RESEARCH (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection
Katharine N. Bossart et al.
PLOS PATHOGENS (2009)
Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, severe acute respiratory syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts
RL Sheets et al.
TOXICOLOGICAL SCIENCES (2006)
A novel electroporation device for gene delivery in large animals and humans
TE Tjelle et al.
VACCINE (2006)
Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function
JD Schertzer et al.
MOLECULAR THERAPY (2006)
A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporation
XD Wang et al.
JOURNAL OF GENE MEDICINE (2005)
Monoclonal antibodies produced by muscle after plasmid injection and electroporation
TE Tjelle et al.
MOLECULAR THERAPY (2004)
Intramuscular plasmid DNA electrotransfer biodistribution and degradation
MF Bureau et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2004)
Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles
MJ Molnar et al.
MOLECULAR THERAPY (2004)
Optimization of electroporation parameters for the intramuscular delivery of plasmids in pigs
AS Khan et al.
DNA AND CELL BIOLOGY (2003)
Mechanisms of in vivo DNA electrotransfer:: Respective contributions of cell electropermeabilization and DNA electrophoresis
S Satkauskas et al.
MOLECULAR THERAPY (2002)
Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters
RD Weeratna et al.
GENE THERAPY (2001)
Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188
J Hartikka et al.
MOLECULAR THERAPY (2001)
Muscle-specific enhancement of gene expression by incorporation of SV/40 enhancer in the expression plasmid
S Li et al.
GENE THERAPY (2001)
Share Paper
